Batimastat, a synthetic inhibitor of matrix metahoproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts

Clinical Cancer Research

Volumn 4, Issue 4, 1998, Pages 985-992

  Giavazzi, Raffaella ^a   Garofalo, Angela ^a   Ferri, Cristina ^a   Lucchini, Valeria ^b   Bone, Elisabeth A ^c   Chiari, Stefania ^b   Brown, Peter D ^c   Nicoletti, M Ines ^a   Taraboletti, Giulia ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c British Biotech Pharmaceuticals Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; CISPLATIN; DOXORUBICIN; MATRIX METALLOPROTEINASE;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CANCER TRANSPLANTATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA; CISPLATIN; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; METALLOENDOPEPTIDASES; MICE; MICE, NUDE; OVARIAN NEOPLASMS; PHENYLALANINE; PROTEASE INHIBITORS; SURVIVAL ANALYSIS; THIOPHENES; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031945505     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kleiner, D. E., Jr., and Stetler-Stevenson, W. G. Structural biochemistry and activation of matrix metalloproteases. Curr. Opin. Cell Biol., 5: 891-897, 1993.
2. Mignatti, P., and Rifkin, D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev., 73: 161-195, 1993.
3. Crawford, H. C., and Matrisian, L. M. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis, 14: 234-245, 1995.
4. Duffy, M. J. The role of proteolytic enzymes in cancer invasion and metastasis. Clin. Exp. Metastasis, 10: 145-155, 1992.
5. Furcht, L. T., Skubitz, A. P., and Fielos, G. B. Tumor cell invasion, matrix metalloproteinases, and the dogma. Lab. Invest., 70: 781-783, 1994.
6. Brown, P. D. Matrix metalloproteinase inhibitors: a new class of anticancer agent. Curr. Opin. Invest. Drug, 2: 617-626, 1993.
7. DeClerck, Y. A., and Imren, S. Protease inhibitors: role and potential therapeutic use in human cancer. Eur. J. Cancer, 30A: 2170-2180, 1994.
8. Dodwell, D. J., and Howell, A. The potential for proteinase inhibition in cancer treatment. Cancer Treat. Rev., 19: 283-296, 1993.
9. Brown, P. D., and Giavazzi, R. Matrix metalloproteinase inhibitions: a review of the anti-tumour activity of batimastat. Ann. Oncol., 6: 967-974, 1995.
10. Chirivi, R., Garofalo, A., Crimmin, M. J., Bawden, L. J., Stoppacciaro, A., Brown, P. D., and Giavazzi, R. Inhibition of the metastatic spread and growth of B16-B16 murine melanome by a synthetic matrix metalloproteinase inhibitor. Int. J. Cancer, 58: 460-464, 1994.
11. Sledge, G. W., Jr., Qulali, M., Goulet, R., Bone, E. A., and Fife, R. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J. Natl. Cancer Inst. (Bethesda), 87: 1546-1550, 1995.
12. Wang, X., Fu, X., Brown, P. D., Crimmin, M. J., and Hoffman, R. M. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res., 54: 4726-4728, 1994.
13. Watson, S. A., Morris, T. M., Robinson, G., Crimmin, M. J., Brown, P. D., and Hardcastle, J. D. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res., 55: 3629-3633, 1995.
14. Taraboletti, G., Garofalo, A., Belotti, D., Drudis, T., Borsotti, P., Scanziani, E., Brown, P. D., and Giavazzi, R. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J. Natl. Cancer Inst. (Bethesda), 87: 293-298, 1995.
15. Davies, B., Brown, P. D., East, N., Crimmin, M. J., and Balkwill, F. R. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res., 33: 2087-2091, 1993.
16. Thigpen, J. T., Bertelsen, K., Eisenhauer, E. A., Hacker, N. F., Lund, B., and Sessa, C. Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapy. Ann. Oncol., 4: S35-S40, 1993.
17. Cannistra, S. A. Cancer of the ovary. N. Engl. J. Med., 329: 1550-1559, 1993.
18. Gasparini, G., and Harris, A. L. Does improved control of tumour growth require an anti-cancer therapy targeting both neoplastic and intratumoral endothelial cells? Eur. J. Cancer, 30A: 201-206, 1994.
19. Teicher, B. A., Sotomayor, E. A., and Huang, Z. D. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res., 52: 6702-6704, 1992.
20. Anderson, I. C., Shipp, M. A., Docherty, A. J. P., and Teicher, B. A. Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res., 56: 715-718, 1996.
21. Massazza, G., Lucchini, V., Tomasoni, A., Peccatori, F., Lampasona, V., Giudici, G., Mangioni, C., Biondi, A., and Giavazzi, R. Malignant behavior and resistance to cisplatin of human ovarian carcinoma xenografts established from the same patient at different stages of the disease. Cancer Res., 51: 6358-6362, 1991.
22. Massazza, G., Tomasoni, A., Lucchini, V., Allavena, P., Erba, E., Colombo, N., Mantovani, A., D'Incalci, M., Mangioni, C., and Giavazzi, R. Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy. Int. J. Cancer, 44: 494-500, 1989.
23. Nicoletti, M. I., Lucchini, V., Massazza, G., Abbott, B. J., D'Incalci, M., and Giavazzi, R. Antitumor activity of taxol (NSC-125973) in human ovarian carcinomas growing in the peritoneal cavity of nude mice. Ann. Oncol., 4: 151-155, 1993.
24. Beattie, G. J., Young, H. A., and Smith, J. F. Phase I study of intra-peritoneal metallo-proteinase inhibitor BB94 in patients with malignant ascites. Ann. Oncol., 5: 15, 1994.
25. Young, T. N., Pizzo, S. V., and Stack, M. S. A plasma membrane-associated component of ovarian adenocarcinoma cells enhances the catalytic efficiency of matrix metalloproteinase-2. J. Biol. Chem., 270: 999-1002, 1995.
26. Naylor, M. S., Stamp, G. W., Davies, B. D., and Balkwill, F. R. Expression and activity of MMPs and their regulators in ovarian cancer. Int. J. Cancer, 58: 50-56, 1994.
27. Partridge, C. A., Jeffrey, J. J., and Malik, A. B. A 96-kDa gelatinase induced by TNF-α contributes to increased microvascular endothelial permeability. Am. J. Physiol., 265: L438-L447, 1993.
28. Nagy, J. A., Masse, E. M., Herzberg, K. T., Meyers, M. S., Yeo, K. T., Yeo, T. K., Sioussat, T. M., and Dvorak, H. F. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperper-meability, and ascites fluid accumulation. Cancer Res., 55: 360-368, 1995.
29. Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., Leber, T. M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L. M., and Woolley, K. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature (Lond.), 370: 555-557, 1994.
30. McGeehan, G. M., Becherer, J. D., Bast, R. C., Jr., Boyer, C. M., Champion, B., Connolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., McElroy, A. B., Nichols, J., Pryzwansky, K. M., Schoenen, F., Sekut, L., Truesdale, A., Verghese, M., Warner, J., and Ways, J. P. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature (Lond.), 370: 558-561, 1994.
31. Bani, M. R., Garofalo, A., Scanziani, E., and Giavazzi, R. Effect of interleukin-1-β on metastasis formation in different tumor systems. J. Natl. Cancer Inst. (Bethesda), 83: 119-123, 1991.
32. Malik, S. T., Griffin, D. B., Fiers, W., and Balkwill, F. R. Paradoxical effects of tumour necrosis factor in experimental ovarian cancer. Int. J. Cancer, 44: 918-925, 1989.
33. Macaulay, V. M., O'Byrne, K. J., Saunders, M. P., Salisbury, A., Long, L., Gleeson, F., Ganesan, T. S., Harris, A. L., and Talbot, D. C. Phase 1 study of matrix metallo-batimastat (BB94) in patients (PTS) with malignant pleural effusions. Br. J. Cancer, 71: 11, 1995.